Latest / PETRI DISH PERSPECTIVES
Episode 65: Apogee Therapeutics
Send us Fan Mail
In this episode of Petri Dish Perspectives, we explore the story of Apogee Therapeutics, one of biotech's newest immunology companies aiming to redefine autoimmune disease through next-generation antibody engineering. Rather than chasing entirely new biological targets, Apogee is focused on improving what already works, developing longer-lasting biologics that could reduce injections from every few weeks to every few months.
We'll dive into the evolution of modern immunology, the science behind cytokines and Fc engineering, how Apogee emerged from biotech incubator Paragon…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.